StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Becton Dickinson (BDX) Highlights Clinical Trial Data for LUTONIX 014 Drug-Coated Balloon Below-the-Knee IDE
November 7, 2018 1:14 PM
BD (NYSE: BDX) today announced the safety and efficacy data from the LUTONIX® Drug-Coated Balloon (DCB) IDE, level 1 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
FDA
Management Comments
Next Articles
BD Announces Clinical Trial Data for the LUTONIX® 014 Drug-Coated Balloon Below-The-Knee IDE Trial
November 7, 2018 12:30 PM
Becton Dickinson (BDX) PT Lowered to $265 at Morgan Stanley
November 7, 2018 7:54 AM
Pre-Open Movers 11/06: (VCEL) (ELF) (MYL) Higher; (ONCS) (FTDR) (RL) Lower (more...)
November 6, 2018 9:24 AM
Becton Dickinson (BDX) Reports In-Line Q4 EPS, Revenues Beat; Offers FY19 EPS Outlook Below Consensus
November 6, 2018 6:02 AM